Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033241
Status:
COMPLETED
Last Update Posted:
2018-01-10
First Post:
2002-04-09
Brief Title:
Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Pancreatic Cancer |
| Unspecified Adult Solid Tumor Protocol Specific |